Bulls were in command of the equity markets for the third day in a row as exuberance returned to the Street amid marginal ease in bond yields and cheap valuations. The US Treasury yield was last quoted at 1.55 per cent while domestic 10-year government bond yield was at 6.2 per cent. Amid a fall in volatility, the benchmark S&P BSE Sensex advanced 254 points, or 0.5 per cent, to end at 51,279.5 levels. On the NSE, the Nifty50 index ended at 15,175 levels, up 76 points or 0.51 per cent. The Sensex and the Nifty hit their respective intra-day highs of 51,430 and 15,218. Despite three straight days of gains, the Nifty 50 Index has failed to cross the resistance level of 15250. Given this, Ashish Biswas of CapitalVia suggests investors to wait for a decisive breakout above 15,250.
Morepen labs eyeing multi-billion dollar global market sanantoniopost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sanantoniopost.com Daily Mail and Mail on Sunday newspapers.
February 12, 2021
×
Firm sets eyes on multi-billion dollar global API (Active Pharmaceutical Ingredients) market with the addition of new molecules
Morepen Laboratories Ltd has set its eyes on multi-billion dollar global API (Active Pharmaceutical Ingredients) market with the addition of new molecules, whose global patents are expiring over next few years, in its bulk drugs portfolio, the firm said here on Friday.
The bulk drug molecules would be in chronic and lifestyle diseases such as anti-diabetic, anti-hypertensive, cholesterol reducers and neuro-psychiatric. These new molecules are currently under development and would come into play in phases over the next 24 to 36 months, Morepen said.